webinar register page

Webinar banner
Exploring the Pathophysiology of Nasal Polyps and Understanding Phase 3 Trial Results of a Treatment Option
Presenters: Kelly J. Montalto, PharmD, and Ahmad Abdrabboh, PharmD, MPH, BCPS
Respiratory & Allergy Medical Unit
US Clinical Development & Medical Affairs
Novartis Pharmaceuticals Corporation

The learning objectives for this program are as follows:
• Recognize the clinical presentation of nasal polyposis
• Understand the role of key cytokines and mediators in the pathogenesis of
nasal polyps
• Learn about the study design, patient population, and clinical trial results from
two Phase III studies

This non-promotional program is for scientific and educational purposes only and is not an accredited continuing medical
education program. The presenters are Novartis employees. The information presented in this program and views
expressed herein does not necessarily reflect the views, policies, or position of the American Rhinologic Society.

Nov 16, 2021 08:00 PM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Wendi Perez.